Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis
Clinical trial NCT01554163 · COMPLETED
Trial details
- NCT number
- NCT01554163
- Sponsor
- Organon and Co
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-03-01
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.